Clincosm LogoSign in Get a demo

NIEPCE: Non-severe Traumatic Injuries Evaluation Using smartPhone Camera for Extra-hospital Regulation

Sponsor
Poitiers University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05404425
Collaborator
(none)
168
Enrollment
1
Location
2
Arms
12
Anticipated Duration (Months)
14
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Photography teletransmission allow a better and optimized dispatching of patients calling an Emergency Medical Call Center (EMCC) for a mild traumatic injury. It has previously been studied for patients to whom an ambulance was sent and therefore presumed to be older or with co-morbidities. The present trial aim to evaluate in the general population, the effect of a smartphone-mediated visioconference in the dispatching of patients calling an EMCC for mild traumatic injury.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Visioconference: live visual injury evaluation
  • Procedure: Control
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
168 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Non-severe Traumatic Injuries Evaluation Using smartPhone Camera for Extra-hospital Regulation
Actual Study Start Date :
Jul 8, 2022
Anticipated Primary Completion Date :
Jul 8, 2023
Anticipated Study Completion Date :
Jul 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Visioconference: live visual injury evaluation

For patients randomized in the intervention group, a live visual evaluation of the injury is performed by the Emergency Medical Call Center physician using a dedicated, secure smartphone app

Procedure: Visioconference: live visual injury evaluation
For patients randomized in the intervention group, a live visual evaluation of the injury is performed by the Emergency Medical Call Center physician using a dedicated, secure smartphone app
Other: Standard Procedure

Usual management of patients

Procedure: Control
For patients randomized in the control group, the evaluation is performed by the Emergency Medical Call Center physician only by pone call

Outcome Measures

Primary Outcome Measures

  1. Proportion of patients dispatched elsewhere than to the nearest hospital [1 year]

    Proportion of patients dispatched elsewhere than to the nearest hospital (left at home for outpatient care / referred to a higher-level hospital / handled by MICA for advanced pre-hospital medical care)

Secondary Outcome Measures

  1. Under-triage [1 year]

    Under-triage : the proportion of patients initially left at home for outpatient care who had to visit an ED within the 10 following days for care related to the initial traumatic injury

  2. Over-triage [1 year]

    Over-triage : the proportion of patients initially dispatched to an ED who could have underwent outpatient care

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • adult patients (≥18 years of age),

  • free of will (not under any guardianship or liberty privation),

  • suffering from Mild Traumatic Injury,

  • availability of a smartphone with internet connection for the patients or witness,

  • consenting to participate in the study

Exclusion Criteria:

  • severe trauma requiring immediate medical assistance

  • trauma associated with head injury, on antiplatelet therapy (APT) or anti-coagulation therapy (ACT)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu of Poitiers Poitiers France 86021

Sponsors and Collaborators

  • Poitiers University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Poitiers University Hospital
ClinicalTrials.gov Identifier:
NCT05404425
Other Study ID Numbers:
  • NIEPCE Trial
First Posted:
Jun 3, 2022
Last Update Posted:
Jul 12, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Wounds and Injuries

Study Results

No Results Posted as of Jul 12, 2022